Abhijit Date to Antiviral Agents
This is a "connection" page, showing publications Abhijit Date has written about Antiviral Agents.
Connection Strength
1.295
-
Mallick S, Sharma P, Yadavalli T, Koganti R, Singh SK, Yoshimura K, Kapoor D, Sutar Y, Adams JS, Annaji M, Shukla D, Date AA. Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection. Int J Pharm. 2026 Apr 25; 695:126672.
Score: 0.826
-
Yadavalli T, Mallick S, Patel P, Koganti R, Shukla D, Date AA. Pharmaceutically Acceptable Carboxylic Acid-Terminated Polymers Show Activity and Selectivity against HSV-1 and HSV-2 and Synergy with Antiviral Drugs. ACS Infect Dis. 2020 11 13; 6(11):2926-2937.
Score: 0.143
-
Kulkarni M, Potdar S, Date AA, Marfatiya A. In Vitro Release Testing of Acyclovir Topical Formulations Using Immersion Cells. Assay Drug Dev Technol. 2021 Feb-Mar; 19(2):75-84.
Score: 0.142
-
Date AA, Shibata A, McMullen E, La Bruzzo K, Bruck P, Belshan M, Zhou Y, Destache CJ. Thermosensitive Gel Containing Cellulose Acetate Phthalate-Efavirenz Combination Nanoparticles for Prevention of HIV-1 Infection. J Biomed Nanotechnol. 2015 Mar; 11(3):416-27.
Score: 0.097
-
Sutar Y, Singh SK, Dhoble S, Mali J, Adams J, Yadavalli T, Date AA, Shukla D. Oral Self-Nanoemulsifying System Containing Ionic Liquid of BX795 Is Effective against Genital HSV-2 Infection in Mice. ACS Infect Dis. 2024 01 12; 10(1):93-106.
Score: 0.044
-
Yadavalli T, Singh SK, Date AA, Shukla D. Tolerability, pharmacokinetics, and anti-herpetic activity of orally administered BX795. Biomed Pharmacother. 2023 Sep; 165:115056.
Score: 0.043